Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy

BACKGROUND: Glioblastoma is the most lethal primary brain malignancy in adults. Standard of care treatment, consisting of temozolomide (TMZ) and adjuvant radiotherapy (RT), mostly does not prevent local recurrence. The inability of drugs to enter the brain, in particular antibody-based drugs and rad...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Nanotheranostics
Auteurs principaux: Gal, Omer, Betzer, Oshra, Rousso-Noori, Liat, Sadan, Tamar, Motiei, Menachem, Nikitin, Maxim, Friedmann-Morvinski, Dinorah, Popovtzer, Rachela, Popovtzer, Aron
Format: Artigo
Langue:Inglês
Publié: 2022
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613745/
https://ncbi.nlm.nih.gov/pubmed/36324626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jnt3040012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires